- Home
- TDW vs ARQT Comparison
TDW vs ARQT Comparison
Compare TDW & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TDW | ARQT |
|---|---|---|
| Founded | 1956 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.3B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | TDW | ARQT |
|---|---|---|
| Price | $73.84 | $22.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $82.00 | $31.86 |
| AVG Volume (30 Days) | 898.2K | ★ 1.2M |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 88.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $376,072,000.00 |
| Revenue This Year | $1.12 | $34.46 |
| Revenue Next Year | $5.56 | $29.77 |
| P/E Ratio | $24.08 | ★ N/A |
| Revenue Growth | N/A | ★ 91.34 |
| 52 Week Low | $31.17 | $11.86 |
| 52 Week High | $88.99 | $31.77 |
Technical Indicators
Market Signals| Indicator | TDW | ARQT |
|---|---|---|
| Relative Strength Index (RSI) | 49.19 | 35.49 |
| Support Level | $47.73 | $22.56 |
| Resistance Level | $82.00 | $27.26 |
| Average True Range (ATR) | 4.00 | 1.24 |
| MACD | -1.27 | -0.26 |
| Stochastic Oscillator | 1.39 | 2.22 |
Price Performance
Historical ComparisonAbout TDW Tidewater Inc.
Tidewater Inc provides marine and transportation services to the offshore energy industry. The company's vessels and associated services support all phases of offshore crude oil and natural gas (also referred to as oil and gas) exploration activities, field development, production, and maintenance, as well as windfarm development and maintenance. Its services include towing and anchor handling for mobile offshore drilling units; transporting supplies and personnel necessary to sustain drilling, workovers, production activities, field abandonment, dismantlement, and restoration activities; and Others. The group manages its business through five segments including the Americas, Asia Pacific, Middle East, Europe/Mediterranean, and West Africa.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.